Lopinavir Completed Phase N/A Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00357552Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
NCT00255840Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities
NCT00414518Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
NCT00413153Metabolic Effects of Switching Kaletra to Boosted Reyataz
NCT00762320Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
NCT00080522Strategies for Delivering Anti-HIV Therapy in South Africa
NCT00100646Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
NCT00102986Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
NCT00034086Study of Anti-HIV Therapy Intensification
NCT00014937Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
NCT00028366Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
NCT00004855Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs